Transplantation of Primary Explants of Human Tumour to Mice Treated with Antilymphocyte Serum [PDF]
Biopsies from 40 human tumours, obtained at operation, have been transplanted to mice treated with antilymphocyte serum (ALS); viable grafts were obtained from 6 tumours.
B. PHILLIPS, J.-C. Gazet
openalex +2 more sources
The intragraft vascularized bone marrow induces secondary donor-specific mystacial pad allograft tolerance [PDF]
IntroductionVascularized bone marrow (VBM) is essential in tolerance induction through chimerism. We hypothesized that the inclusion of VBM contributes to the induction of mystacial pad allotransplantation tolerance.MethodIn this study, 19 VBM, nine ...
Cheng-Hung Lin +6 more
doaj +2 more sources
Avenues of future research in homotransplantation of the liver with particular reference to hepatic supportive procedures, antilymphocyte serum, and tissue typing [PDF]
Three general areas of research which bear on the developing field of liver transplantation are reviewed. These are: (1) the prospects of obtaining better immunosuppression with particular reference to heterologous antilymphocyte serum; (2) the possible ...
Anderson +31 more
core +3 more sources
Immunodulation of intestinal transplantation: antilymphocyte serum donor pretreatment vs. ex vivo graft irradiation. [PDF]
Nakao A +6 more
europepmc +3 more sources
Effect of Antilymphocyte Serum on Animals Experimentally Infected withHistoplasma capsulatum or Cryptococcus neoformans [PDF]
David M. Adamson, George C. Cozad
openalex +2 more sources
Induction of Immunological Tolerance to Tissue Allografts with Antilymphocyte Serum [PDF]
Our interest in the problem of tolerance induction is directly concerned with clinical organ transplantation. ALS is highly effective in depressing cellular immunities.
Hardy, Mark A., Monaco, Anthony P.
core +3 more sources
CD4+ Regulatory T Cells Are Spared from Deletion by Antilymphocyte Serum, a Polyclonal Anti-T Cell Antibody [PDF]
Keisuke Minamimura +2 more
openalex +2 more sources
Usefulness of valacyclovir prophylaxis for cytomegalovirus infection after anti-thymocyte globulin as rejection therapy [PDF]
Background/Aims Anti-thymocyte globulin (ATG) treatment for acute T-cell mediated rejection (TCMR) can increase the risk of cytomegalovirus (CMV) infection.
Eun Jeong Ko +3 more
doaj +1 more source

